Valuation: H&R GmbH & Co. KGaA

Market Cap 24Cr 27Cr 22Cr 20Cr 38Cr 2.61TCr 39Cr 263.07Cr 102.78Cr 1.28TCr 101.82Cr 100Cr 4.44TCr P/E 2026 *
7.22x
P/E 2027 * 21.4x
Enterprise Value 26Cr 30Cr 24Cr 22Cr 42Cr 2.86TCr 43Cr 288.32Cr 112.65Cr 1.41TCr 111.59Cr 109.19Cr 4.87TCr EV / Sales 2026 *
0.2x
EV / Sales 2027 * 0.19x
Free-Float
21.97%
Yield 2026 *
0.78%
Yield 2027 * 0.78%
15/05 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
31/03 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
28/01 Kepler Cheuvreux Favors BASF and Bayer, Avoids H&R and Evonik DP
15/11 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
14/11 H&R GmbH & Co. KGaA Revises Earnings Guidance for the Full Year 2025 CI
25/25/25 Nils Hansen acquired additional 7.78% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?15 million. CI
15/25/15 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
16/25/16 Nils Hansen proposed to acquire remaining 38.55% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?73 million. CI
14/25/14 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
17/25/17 H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 CI
09/25/09 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
27/25/27 H&R GmbH & Co. KGaA Says Postponement Of The Publication Of The Consolidated Financial Statements And The Annual Report 2024 RE
27/25/27 H&R GmbH & Co. KGaA Announces Postponement of the Publication of the Consolidated Financial Statements and the Annual Report 2024 CI
1 day-2.14%
1 week-0.62%
Current month+28.77%
1 month+31.42%
3 months+39.13%
6 months+47.13%
Current year+49.18%
1 week 6.08
Extreme 6.08
6.68
1 month 4.51
Extreme 4.51
6.68
Current year 3.91
Extreme 3.91
6.68
1 year 3.91
Extreme 3.91
6.68
3 years 3.23
Extreme 3.23
6.68
5 years 3.23
Extreme 3.23
10.35
10 years 3.23
Extreme 3.23
19.58
Manager TitleAgeSince
Chief Executive Officer 61 01/01/2016
Investor Relations Contact - 01/01/2006
Director TitleAgeSince
Chairman 62 17/04/2012
Director/Board Member 71 01/05/2011
Director/Board Member 69 01/05/2011
Change 5-day change 1-year change 3-year change Capi.($)
-2.14%-0.62%+28.51%+23.55% 28Cr
+0.54%+0.03%+12.30%+32.85% 13TCr
-9.90%-10.80%+447.84%+153.57% 4.83TCr
-0.84%+0.95%-2.58%-37.91% 4.23TCr
-2.30%+5.30%+17.98%-19.84% 3.49TCr
-3.75%+9.77%+44.59%+74.61% 2.61TCr
-2.27%+1.94%-0.63%-33.58% 1.99TCr
-2.76%+12.64%+62.06%+240.10% 1.84TCr
-5.78%+4.28%+290.86%+526.84% 1.76TCr
-0.68%+0.15%+25.37%+391.29% 1.74TCr
Average -2.99%+1.55%+92.63%+135.15% 3.52TCr
Weighted average by Cap. -2.37%+0.63%+89.68%+88.30%

Financials

2026 *2027 *
Net sales 133.05Cr 151.49Cr 123.73Cr 113.54Cr 213.34Cr 15TCr 216.62Cr 1.47TCr 574.04Cr 7.17TCr 568.68Cr 556.42Cr 25TCr 133.28Cr 151.74Cr 123.94Cr 113.73Cr 213.7Cr 15TCr 216.99Cr 1.47TCr 575.01Cr 7.18TCr 569.64Cr 557.36Cr 25TCr
Net income 93L 1.06Cr 86.49L 79.36L 1.49Cr 101.97Cr 1.51Cr 10Cr 4.01Cr 50Cr 3.97Cr 3.89Cr 173.33Cr 1.13Cr 1.29Cr 1.05Cr 96.43L 1.81Cr 123.9Cr 1.84Cr 12Cr 4.88Cr 61Cr 4.83Cr 4.73Cr 210.61Cr
Net Debt 2.29Cr 2.6Cr 2.13Cr 1.95Cr 3.67Cr 250.73Cr 3.72Cr 25Cr 9.87Cr 123.27Cr 9.77Cr 9.56Cr 426.2Cr 86.51L 98.49L 80.45L 73.82L 1.39Cr 95Cr 1.41Cr 9.55Cr 3.73Cr 47Cr 3.7Cr 3.62Cr 161.23Cr
Logo H&R GmbH & Co. KGaA
H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Employees
1,692
Date Price Change Volume
24/26/24 €6.400 -2.14% 12,518
23/26/23 €6.540 +1.87% 19,390
22/26/22 €6.420 -0.93% 6,110
21/26/21 €6.480 +1.57% 31,979
20/26/20 €6.380 -0.93% 20,209
Trader
Investor
Global
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.400EUR
Average target price
6.250EUR
Spread / Average Target
-2.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2HRA Stock